title: Tyrosine phosphorylation in peripheral lymphocytes from patients with systemic lupus erythematosus.
abstract: A comparative study of tyrosine phosphorylation was performed on peripheral blood lymphocytes from systemic lupus erythematosus (SLE) patients and from healthy donors. Freshly isolated SLE lymphocytes presented an elevated tyrosine phosphorylation level when compared to healthy donors lymphocytes (p = 0.005). Among all phosphorylated proteins, those called p120, p110, p80 and p55-p60 were more phosphorylated. The level of tyrosine phosphorylation of p120 and p110 proteins discriminated significantly (p = 0.0048, respectively, p = 0.02) between SLE patients and healthy donors. Lymphocytes form SLE patients and healthy donors were then stimulated by cross-linking T cell antigens (CD3, CD4, CD8) to further distinguish the signal transduction between normal and pathologic lymphocytes. No statistical differences in the tyrosine phosphorylation pattern, following CD4 or CD8 cross-linking, were observed between SLE patients and healthy donors lymphocytes. CD3 cross-linking induced an effect on tyrosine phosphorylation different in SLE patients versus healthy donors lymphocytes. Thus, the lymphocytes of SLE patients were refractile in anti-CD3 stimulation in comparison with the healthy donors lymphocytes. Chi-square analysis demonstrated that a significantly larger number of healthy donors responded to anti-CD3 stimulation compared to SLE patients (p = 0.03). The high frequency of tyrosine phosphorylation of p110 and p80 proteins, following CD3 stimulation, in normal versus SLE lymphocytes, suggested that these proteins could be involved in abnormal signal transduction in SLE cells.
authors.affiliation: Department of Immunology, Cantacuzino Institute, Bucharest, Romania.
authors.forename: C
authors.initials: C
authors.lastname: Matache
authors.forename: M
authors.initials: M
authors.lastname: Stefanescu
authors.forename: A
authors.initials: A
authors.lastname: Onu
authors.forename: G
authors.initials: G
authors.lastname: Szegli
authors.forename: M
authors.initials: M
authors.lastname: Barel
authors.forename: S
authors.initials: S
authors.lastname: Tanaseanu
authors.forename: I
authors.initials: I
authors.lastname: Matei
authors.forename: S
authors.initials: S
authors.lastname: Bouillie
authors.forename: R
authors.initials: R
authors.lastname: Frade
mesh_terms: D017252:CD3 Complex / Q000276:immunology; D015704:CD4 Antigens / Q000276:immunology; D016827:CD8 Antigens / Q000276:immunology; D003432:Cross-Linking Reagents; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000276:immunology*; D008214:Lymphocytes / Q000276:immunology / Q000378:metabolism*; D010766:Phosphorylation; D014443:Tyrosine / Q000378:metabolism*
chemical_list: D017252:CD3 Complex; D015704:CD4 Antigens; D016827:CD8 Antigens; D003432:Cross-Linking Reagents; D014443:Tyrosine